Tsuji G, Hashimoto-Hachiya A, Yen VH, Takemura M, Yumine A, Furue K, Furue M, Nakahara T
Clinical trials used doses of 0.3 4.5 mg/week, at a 2.5 mg/ml concentration, a 2.4 mg dose = 0.96 ml = 96 IU on the insulin syringe
Each component (BPC-157, TB-500) is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024
Based on the policy finalized in this section to pay separately at arithmetic MUC for any diagnostic radiopharmaceutical with a HCPCS code and claims data, and with a per-day cost greater than $655 using the methodology previously described, the HCPCS codes that describe diagnostic radiopharmaceuticals with per day costs that exceed the finalized diagnostic radiopharmaceutical packaging threshold are assigned to a status indicator of K, indicating separate payment to be paid based on that HCPCS code's arithmetic MUC
It inhibits the replication of herpes simplex virus 1 (HSV-1) in human foreskin fibroblasts when used at concentrations of 5 and 10 mM
Sterile water for injection